熟悉美股生物医药的投资者都应该听说过催化剂这个概念。所谓催化剂一般是指处在研发阶段生物医药公司公布临床数据或者美国药监局(FDA)批准即将上市的药物。这种催化剂的重要性不言而喻,临床数据好的话股价很有可能会一飞冲天,临床数据差公司股价被腰...查看全文
牛唐2019-03-18 18:19
$Rhythm制药(RYTM)$ 的Setmelanotide预计月底前发布代谢综合症三期的update data,三季度前发布三期的topline data,药物有BTD和孤儿药的认定,过往数据也不错,大家可以逢低配置,主要的竞品是$Agios制药(AGIO)$ 的Mitapivat和$Acer医疗(ACER)$ 的Edsivo ,前者进度比RYTM慢 ,后者今年6月25日FDA...查看全文
$Acer医疗(ACER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-020441 Size: 6 KB 网页链接
$Acer医疗(ACER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-020443 Size: 6 KB 网页链接
$Acer医疗(ACER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-020445 Size: 6 KB 网页链接
$Acer医疗(ACER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-020438 Size: 6 KB 网页链接
$Acer医疗(ACER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-020439 Size: 6 KB 网页链接
$Acer医疗(ACER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-020440 Size: 6 KB 网页链接
$Acer医疗(ACER)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-065159 Act: 34 Size: 10 MB 网页链接
$Acer医疗(ACER)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-280692 Act: 33 Size: 34 KB 网页链接
$Acer医疗(ACER)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-280696 Act: 33 Size: 34 KB 网页链接
$Acer医疗(ACER)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-280698 Act: 33 Size: 34 KB 网页链接